LB-301

N/A

Report date: 2023/10/26 16:55:32

Base Information

Drug NameLB-301
Drug Alias NameLB-301
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGene transferenceUGT1A1 enzyme replacements
TargetsUDP-glucuronosyltransferase 1-1
Therapy Area/IndicationsCrigler-Najjar Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLogicbio Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesLogicbio Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCrigler-Najjar Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A